No significant differences were observed between the treated and control groups, even if a clear trend was evident: indeed, the treated patients were always treated less.
← all excerpts
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial.
1
—
—